IDEXX LABORATORIES INC /DE Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IDEXX LABORATORIES INC /DE for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | M | 160.28 | 3,046 | 488,213 | 0 | |
Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 513.41 | 3,046 | 1,563,840 | 14,696 | 17.7 K to 14.7 K (-17.17 %) |
Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Buy | M | 160.28 | 3,046 | 488,213 | 17,742 | 14.7 K to 17.7 K (+20.73 %) |
Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 67.85 | 1,476 | 100,147 | 0 | |
Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 67.85 | 1,476 | 100,147 | 654,213 | 652.7 K to 654.2 K (+0.23 %) |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | M | 206.94 | 483 | 99,952 | 1,449 | |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Buy | M | 206.94 | 483 | 99,952 | 1,878 | 1.4 K to 1.9 K (+34.62 %) |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 67.85 | 1,475 | 100,079 | 0 | |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 67.85 | 1,475 | 100,079 | 55,697 | 54.2 K to 55.7 K (+2.72 %) |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 85.00 | 1,000 | 85,000 | 4,902 | |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 79.54 | 898 | 71,427 | 0 | |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 538.57 | 1,888 | 1,016,815 | 2,875 | 4.8 K to 2.9 K (-39.64 %) |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 539.19 | 10 | 5,392 | 4,763 | 4.8 K to 4.8 K (-0.21 %) |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 85.00 | 1,000 | 85,000 | 4,773 | 3.8 K to 4.8 K (+26.50 %) |
Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 79.54 | 898 | 71,427 | 3,773 | 2.9 K to 3.8 K (+31.23 %) |
Feb 19 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 67.85 | 1,474 | 100,011 | 0 | |
Feb 19 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 67.85 | 1,474 | 100,011 | 26,188 | 24.7 K to 26.2 K (+5.96 %) |
Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | M | 160.28 | 1,125 | 180,315 | 1,921 | |
Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | M | 85.00 | 5,902 | 501,670 | 0 | |
Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 537.19 | 586 | 314,795 | 0 | 586 to 0 (-100.00 %) |
Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 536.89 | 6,745 | 3,621,293 | 586 | 7.3 K to 586 (-92.01 %) |
Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Buy | M | 160.28 | 1,125 | 180,315 | 7,331 | 6.2 K to 7.3 K (+18.13 %) |
Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Buy | M | 85.00 | 5,902 | 501,670 | 6,206 | 304 to 6.2 K (+1,941.45 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 217 | 0 | 2,649 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 453 | 0 | 2,866 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | A | 0.00 | 551 | 0 | 3,349 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | A | 544.08 | 5,119 | 2,785,146 | 5,119 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Payment of Exercise | F | 544.08 | 208 | 113,169 | 1,395 | 1.6 K to 1.4 K (-12.98 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Buy | M | 0.00 | 217 | 0 | 1,603 | 1.4 K to 1.6 K (+15.66 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Buy | M | 0.00 | 483 | 0 | 1,386 | 903 to 1.4 K (+53.49 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 184 | 0 | 1,965 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 157 | 0 | 2,149 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 168 | 0 | 2,306 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 212 | 0 | 2,474 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 405 | 0 | 2,686 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | A | 0.00 | 459 | 0 | 3,091 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | A | 544.08 | 4,236 | 2,304,723 | 4,236 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Payment of Exercise | F | 544.08 | 338 | 183,899 | 13,723 | 14.1 K to 13.7 K (-2.40 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 184 | 0 | 14,061 | 13.9 K to 14.1 K (+1.33 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 157 | 0 | 13,877 | 13.7 K to 13.9 K (+1.14 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 168 | 0 | 13,720 | 13.6 K to 13.7 K (+1.24 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 212 | 0 | 13,552 | 13.3 K to 13.6 K (+1.59 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 405 | 0 | 13,340 | 12.9 K to 13.3 K (+3.13 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 163 | 0 | 2,005 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 181 | 0 | 2,168 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 210 | 0 | 2,349 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 212 | 0 | 2,559 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 221 | 0 | 2,771 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | A | 0.00 | 345 | 0 | 2,992 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | A | 544.08 | 3,131 | 1,703,514 | 3,131 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Payment of Exercise | F | 544.08 | 388 | 211,103 | 10,754 | 11.1 K to 10.8 K (-3.48 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 163 | 0 | 11,142 | 11 K to 11.1 K (+1.48 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 181 | 0 | 10,979 | 10.8 K to 11 K (+1.68 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 210 | 0 | 10,798 | 10.6 K to 10.8 K (+1.98 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 212 | 0 | 10,588 | 10.4 K to 10.6 K (+2.04 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 221 | 0 | 10,376 | 10.2 K to 10.4 K (+2.18 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 217 | 0 | 2,074 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 2,291 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,418 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 150 | 0 | 2,544 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 243 | 0 | 2,694 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 0.00 | 643 | 0 | 2,937 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 544.08 | 6,003 | 3,266,112 | 6,003 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Payment of Exercise | F | 544.08 | 257 | 139,829 | 18,427 | 18.7 K to 18.4 K (-1.38 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 217 | 0 | 18,684 | 18.5 K to 18.7 K (+1.18 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 18,467 | 18.3 K to 18.5 K (+0.69 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 18,340 | 18.2 K to 18.3 K (+0.69 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 18,340 | 18.2 K to 18.3 K (+0.69 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 150 | 0 | 18,214 | 18.1 K to 18.2 K (+0.83 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 243 | 0 | 18,064 | 17.8 K to 18.1 K (+1.36 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 433 | 0 | 5,850 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 435 | 0 | 6,283 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 6,718 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 7,223 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 810 | 0 | 7,682 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 1,011 | 0 | 8,492 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 544.08 | 9,538 | 5,189,435 | 9,538 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 539.58 | 1,307 | 705,231 | 24,714 | 26 K to 24.7 K (-5.02 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 544.08 | 1,335 | 726,347 | 26,021 | 27.4 K to 26 K (-4.88 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 433 | 0 | 27,356 | 26.9 K to 27.4 K (+1.61 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 435 | 0 | 26,923 | 26.5 K to 26.9 K (+1.64 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 26,488 | 26 K to 26.5 K (+1.94 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 25,983 | 25.5 K to 26 K (+1.80 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 810 | 0 | 25,524 | 24.7 K to 25.5 K (+3.28 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 974 | 0 | 9,990 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 435 | 0 | 10,964 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 505 | 0 | 11,399 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 459 | 0 | 11,904 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 737 | 0 | 12,363 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 0.00 | 2,757 | 0 | 13,100 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 598.49 | 183 | 109,523 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 598.49 | 9,717 | 5,815,508 | 9,717 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 544.08 | 17,674 | 9,616,070 | 17,674 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Payment of Exercise | F | 544.08 | 1,447 | 787,284 | 43,090 | 44.5 K to 43.1 K (-3.25 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 974 | 0 | 44,537 | 43.6 K to 44.5 K (+2.24 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 435 | 0 | 43,563 | 43.1 K to 43.6 K (+1.01 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 505 | 0 | 43,128 | 42.6 K to 43.1 K (+1.18 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 459 | 0 | 42,623 | 42.2 K to 42.6 K (+1.09 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 737 | 0 | 42,164 | 41.4 K to 42.2 K (+1.78 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 174 | 0 | 2,308 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 181 | 0 | 2,482 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 196 | 0 | 2,663 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 2,859 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,071 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 0.00 | 643 | 0 | 3,292 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 544.08 | 6,003 | 3,266,112 | 6,003 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Sell | S | 545.00 | 850 | 463,250 | 3,624 | 4.5 K to 3.6 K (-19.00 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Payment of Exercise | F | 544.08 | 314 | 170,841 | 4,474 | 4.8 K to 4.5 K (-6.56 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 174 | 0 | 4,768 | 4.6 K to 4.8 K (+3.79 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 181 | 0 | 4,594 | 4.4 K to 4.6 K (+4.10 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 196 | 0 | 4,413 | 4.2 K to 4.4 K (+4.65 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 4,217 | 4 K to 4.2 K (+5.29 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 4,005 | 3.8 K to 4 K (+5.84 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 174 | 0 | 1,882 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 2,056 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 88 | 0 | 2,309 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 199 | 0 | 2,397 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 0.00 | 643 | 0 | 2,596 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 544.08 | 6,003 | 3,266,112 | 6,003 | |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Payment of Exercise | F | 544.08 | 216 | 117,521 | 8,083 | 8.3 K to 8.1 K (-2.60 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 174 | 0 | 8,299 | 8.1 K to 8.3 K (+2.14 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 8,125 | 8 K to 8.1 K (+1.59 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 7,998 | 7.9 K to 8 K (+1.60 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 88 | 0 | 7,872 | 7.8 K to 7.9 K (+1.13 %) |
Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 199 | 0 | 7,784 | 7.6 K to 7.8 K (+2.62 %) |
Feb 16 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 160.28 | 3,046 | 488,213 | 0 | |
Feb 16 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 538.20 | 3,046 | 1,639,357 | 3,321 | 6.4 K to 3.3 K (-47.84 %) |
Feb 16 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 160.28 | 3,046 | 488,213 | 6,367 | 3.3 K to 6.4 K (+91.72 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 85.00 | 5,902 | 501,670 | 0 | |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 64.69 | 5,974 | 386,458 | 0 | |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 10,217 | 0 to 10.2 K |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 10,217 | 0 to 10.2 K |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 10,217 | 0 | 0 | 10.2 K to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 492.40 | 300 | 147,718 | 0 | 300 to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 491.56 | 1,100 | 540,716 | 300 | 1.4 K to 300 (-78.57 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 490.70 | 3,399 | 1,667,879 | 1,400 | 4.8 K to 1.4 K (-70.83 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 489.23 | 4,286 | 2,096,836 | 4,799 | 9.1 K to 4.8 K (-47.18 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 488.24 | 2,791 | 1,362,666 | 9,085 | 11.9 K to 9.1 K (-23.50 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 11,876 | 0 | 11,876 | 0 to 11.9 K |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 11,876 | 0 | 0 | 11.9 K to 0 (-100.00 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 85.00 | 5,902 | 501,670 | 11,876 | 6 K to 11.9 K (+98.79 %) |
Feb 08 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 64.69 | 5,974 | 386,458 | 5,974 | 0 to 6 K |
Feb 03 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 478.68 | 13 | 6,223 | 2,875 | 2.9 K to 2.9 K (+0.45 %) |
Feb 03 2021 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 478.68 | 42 | 20,105 | 993 | 951 to 993 (+4.42 %) |